Financial Daily from THE HINDU group of publications
Sunday, Jan 22, 2006


News
Features
Stocks
Shipping
Archives
Google

Group Sites

Home Page - Pharmaceuticals
Industry & Economy - Anti-dumping


Anti-dumping probe initiated on pen-G imports from China

K.R. Srivats

New Delhi , Jan. 21

LOW-priced Chinese made penicillin-G imports continue to have a telling effect on the fortunes of the domestic industry manufacturing the drug.

SPIC Ltd, a pen-G manufacturer, has approached the Anti-dumping Directorate in the Commerce Ministry and has sought a probe on the alleged dumping of penicillin-G imports from China.

Based on SPIC's application, the Designated Authority in the Commerce Ministry has initiated an anti-dumping probe on all penicillin-G imports from China. Pen-G finds application in the manufacture of antibiotics such as ampicillin, amoxycillin and cloxacillin. While SPIC had, in its application, claimed that there are three more producers of pen-G in the country, the Designated Authority has noted that J.K. Pharma closed its plant, Alembic Ltd suspended production in 2004 and Torrent Biotech also suspended production in September 2005.

Related Stories:
Dumping probe on pentaerythritol from China, Sweden

More Stories on : Pharmaceuticals | Anti-dumping

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
TN Govt introduces Bill to take over MSOs — Street-level cable operators out of purview


Wrong signal, says Kamal Nath
Jet Air net dips 53 pc on fuel price hike
Cites payroll, lease rental costs as other reasons

The Big B factor in Jet-Sahara deal
Anti-dumping probe initiated on pen-G imports from China
Revised position limits on stock-based derivatives from Jan 27
MTNL yet to comply with Clause 49


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line